Aim 1: Determine if there is an association between the APOL1 risk variants and allograft survival and function in African Americans Aim 2: Determine if there is an association between the presence of APOL1 risk variants in an African American kidney transplant recipient and the risk of recurrent disease Aim 3: Investigate mechanisms of APOL1 associated kidney disease by prospectively following African American kidney transplant recipients throughout their clinical course.
Study Type
OBSERVATIONAL
Enrollment
39
Brigham and Women's Hospital
Boston, Massachusetts, United States
Allograft survival
Time frame: year 1, 3, 5
Allograft function as measured by serum creatinine
Time frame: creatinine levels at year-1, year-3 and year-5
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.